Biomedical Research Center: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
→‎Research with Impact: rewrite the introduction to eliminate ambiguity
consistent citation formatting; templated cites
Line 24: Line 24:
| website = http://www.qu.edu.qa/research/brc
| website = http://www.qu.edu.qa/research/brc
}}
}}
The '''Biomedical Research Center''' (BRC) is a research center at [[Qatar University]] focusing on biomedical research. BRC was founded in 2014, and partners with the [[Ministry of Public Health (Qatar)]], and [[Hamad Medical Corporation|Hamad Medical Corporation (HMC)]].<ref>{{Cite web |date=2015-11-05 |title=BRC AND SCH SIGN COLLABORATIVE AGREEMENT |url=http://www.qu.edu.qa/newsroom/BRC/BRC-and-SCH-sign-collaborative-agreement |access-date= |website=www.qu.edu.qa}}</ref><ref name=":1">{{Cite web |date=2023 |title=Biomedical Research Center {{!}} Qatar University |url=http://www.qu.edu.qa/research/brc |access-date= |website=www.qu.edu.qa}}</ref><ref>{{Cite journal |date=2023 |title=Qatar puts the pursuit of knowledge front and centre |url=https://www.nature.com/articles/d42473-018-00045-9 |journal= |language=en}}</ref>
The '''Biomedical Research Center''' (BRC) is a research center at [[Qatar University]] focusing on biomedical research. BRC was founded in 2014, and partners with the [[Ministry of Public Health (Qatar)]], and [[Hamad Medical Corporation|Hamad Medical Corporation (HMC)]].<ref>{{Cite web |date=2015-11-05 |title=BRC AND SCH SIGN COLLABORATIVE AGREEMENT |url=http://www.qu.edu.qa/newsroom/BRC/BRC-and-SCH-sign-collaborative-agreement |access-date= |website=www.qu.edu.qa}}</ref><ref name=":1">{{Cite web |date=2023 |title=Biomedical Research Center {{!}} Qatar University |url=http://www.qu.edu.qa/research/brc |access-date= |website=www.qu.edu.qa}}</ref><ref>{{Cite web |date=2023 |title=Qatar puts the pursuit of knowledge front and centre |url=https://www.nature.com/articles/d42473-018-00045-9 |language=en}}</ref>


== Background ==
== Background ==
Line 46: Line 46:
The following are some of research projects that demonstrate BRC commitment to research that is tackling the national problems, and beyond:
The following are some of research projects that demonstrate BRC commitment to research that is tackling the national problems, and beyond:


* [[Antibiotic|Antibiotic profiling]] of antibiotics resistant microbes in humans and animals<ref>{{Cite journal |last=El Zowalaty |first=Mohamed E |last2=Al Thani |first2=Asmaa A |last3=Webster |first3=Thomas J |last4=El Zowalaty |first4=Ahmed E |last5=Schweizer |first5=Herbert P |last6=Nasrallah |first6=Gheyath K |last7=Marei |first7=Hany E |last8=Ashour |first8=Hossam M |date=2015-10-01 |title=Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies |url=https://www.futuremedicine.com/doi/abs/10.2217/fmb.15.48 |journal=Future Microbiology |volume=10 |issue=10 |pages=1683–1706 |doi=10.2217/fmb.15.48 |issn=1746-0913}}</ref><ref>{{Cite web |date=2022 |title=Microbiome engineering to combat antimicrobial resistance and upsurge productivity of food animals: a systematic review |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85139730874&origin=resultslist&sort=plf-f&src=s&st1=Microbiome+engineering+to+combat+antimicrobial+resistance+and+upsurge+productivity+of+food+animals%3a+a+systematic+review&sid=c335234ba095871886face978b45d6e0&sot=b&sdt=b&sl=124&s=ALL%28Microbiome+engineering+to+combat+antimicrobial+resistance+and+upsurge+productivity+of+food+animals%3a+a+systematic+review%29&relpos=0&citeCnt=0&searchTerm= |access-date= |website=www.scopus.com}}</ref> <ref>{{Cite web |date=26 June 2018 |title=Prevalence of antibiotic resistant Escherichia coli isolates from fecal samples of food handlers in Qatar |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85049090569&origin=resultslist&sort=plf-f |access-date= |website=www.scopus.com}}</ref><ref>{{Cite web |date=1 July 2022 |title=Retail Chicken Carcasses as a Reservoir of Multidrug-Resistant Salmonella |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85134431088&origin=resultslist&sort=plf-f |access-date= |website=www.scopus.com}}</ref> (One health approach).<ref name=":4">{{Cite web |last=Newspaper |first=The Peninsula |date=2020-03-29 |title=Qatar University’s Biomedical Research Center conducting research on COVID-19 |url=https://thepeninsulaqatar.com/article/29/03/2020/Qatar-University%E2%80%99s-Biomedical-Research-Center-conducting-research-on-COVID-19 |access-date=2023-03-14 |website=thepeninsulaqatar.com |language=en}}</ref>
* [[Antibiotic|Antibiotic profiling]] of antibiotics resistant microbes in humans and animals<ref>{{cite journal | vauthors = El Zowalaty ME, Al Thani AA, Webster TJ, El Zowalaty AE, Schweizer HP, Nasrallah GK, Marei HE, Ashour HM | display-authors = 6 | title = Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies | journal = Future Microbiology | volume = 10 | issue = 10 | pages = 1683–1706 | date = 2015-10-01 | pmid = 26439366 | doi = 10.2217/fmb.15.48 }}</ref><ref>{{cite journal | vauthors = Johar AR, Abu-Rub LI, Al Mana H, Yassine HM, Eltai NO | title = Microbiome engineering to combat antimicrobial resistance and upsurge productivity of food animals: a systematic review. | journal = Animal Production Science | date = September 2022 | doi = 10.1071/AN22233 }}</ref><ref name="pmid29983931">{{cite journal | vauthors = Eltai NO, Yassine HM, Al Thani AA, Abu Madi MA, Ismail A, Ibrahim E, Alali WQ | title = Prevalence of antibiotic resistant <i>Escherichia coli</i> isolates from fecal samples of food handlers in Qatar | journal = Antimicrobial Resistance and Infection Control | volume = 7 | issue = | pages = 78 | date = 2018 | pmid = 29983931 | pmc = 6019201 | doi = 10.1186/s13756-018-0369-2 }}</ref><ref name="pmid35675669">{{cite journal | vauthors = Al-Hadidi SH, Al Mana H, Almoghrabi SZ, El-Obeid T, AlAli WQ, Eltai NO | title = Retail Chicken Carcasses as a Reservoir of Multidrug-Resistant Salmonella | journal = Microbial Drug Resistance | location = Larchmont, N.Y. | volume = 28 | issue = 7 | pages = 824–831 | date = July 2022 | pmid = 35675669 | pmc = 9347385 | doi = 10.1089/mdr.2021.0414 }}</ref> (One health approach).<ref name=":4">{{Cite web | work = The Peninsula Newspaper |date=2020-03-29 |title=Qatar University’s Biomedical Research Center conducting research on COVID-19 |url=https://thepeninsulaqatar.com/article/29/03/2020/Qatar-University%E2%80%99s-Biomedical-Research-Center-conducting-research-on-COVID-19 |access-date=2023-03-14 |language=en}}</ref>
* Identified for the first time the reason of why some obese people gets type-2 [[diabetes]] while others do not.<ref>{{Cite journal |last=Al-Sulaiti |first=Haya |last2=Diboun |first2=Ilhame |last3=Agha |first3=Maha V. |last4=Mohamed |first4=Fatima F. S. |last5=Atkin |first5=Stephen |last6=Dömling |first6=Alex S. |last7=Elrayess |first7=Mohamed A. |last8=Mazloum |first8=Nayef A. |date=2019-10-22 |title=Metabolic signature of obesity-associated insulin resistance and type 2 diabetes |url=https://pubmed.ncbi.nlm.nih.gov/31640727/ |journal=Journal of Translational Medicine |volume=17 |issue=1 |pages=348 |doi=10.1186/s12967-019-2096-8 |issn=1479-5876 |pmc=6805293 |pmid=31640727}}</ref><ref>{{Cite web |date=December 2019 |title=WCM-Q research probes causal link between obesity and diabetes |url=https://qatar-weill.cornell.edu/media-and-news/news/story/wcm-q-research-probes-causal-link-between-obesity-and-diabetes |access-date= |website=Latest News - Weill Cornell Medicine - Qatar |language=en-US}}</ref>
* Identified for the first time the reason of why some obese people gets type-2 [[diabetes]] while others do not.<ref>{{cite journal | vauthors = Al-Sulaiti H, Diboun I, Agha MV, Mohamed FF, Atkin S, Dömling AS, Elrayess MA, Mazloum NA | display-authors = 6 | title = Metabolic signature of obesity-associated insulin resistance and type 2 diabetes | journal = Journal of Translational Medicine | volume = 17 | issue = 1 | pages = 348 | date = October 2019 | pmid = 31640727 | pmc = 6805293 | doi = 10.1186/s12967-019-2096-8 }}</ref><ref>{{Cite web |date=December 2019 |title=WCM-Q research probes causal link between obesity and diabetes |url=https://qatar-weill.cornell.edu/media-and-news/news/story/wcm-q-research-probes-causal-link-between-obesity-and-diabetes |access-date= |website=Latest News - Weill Cornell Medicine - Qatar |language=en-US}}</ref>
* Conducted six research on [[COVID-19]]<ref>{{Cite journal |last=Wang |first=Lingshu |last2=Shi |first2=Wei |last3=Joyce |first3=M. Gordon |last4=Modjarrad |first4=Kayvon |last5=Zhang |first5=Yi |last6=Leung |first6=Kwanyee |last7=Lees |first7=Christopher R. |last8=Zhou |first8=Tongqing |last9=Yassine |first9=Hadi M. |last10=Kanekiyo |first10=Masaru |last11=Yang |first11=Zhi-yong |last12=Chen |first12=Xuejun |last13=Becker |first13=Michelle M. |last14=Freeman |first14=Megan |last15=Vogel |first15=Leatrice |date=2015-07-28 |title=Evaluation of candidate vaccine approaches for MERS-CoV |url=https://www.nature.com/articles/ncomms8712 |journal=Nature Communications |language=en |volume=6 |issue=1 |pages=7712 |doi=10.1038/ncomms8712 |issn=2041-1723}}</ref><ref>{{Cite journal |last=Chemaitelly |first=Hiam |last2=Yassine |first2=Hadi M. |last3=Benslimane |first3=Fatiha M. |last4=Al Khatib |first4=Hebah A. |last5=Tang |first5=Patrick |last6=Hasan |first6=Mohammad R. |last7=Malek |first7=Joel A. |last8=Coyle |first8=Peter |last9=Ayoub |first9=Houssein H. |last10=Al Kanaani |first10=Zaina |last11=Al Kuwari |first11=Einas |last12=Jeremijenko |first12=Andrew |last13=Kaleeckal |first13=Anvar Hassan |last14=Latif |first14=Ali Nizar |last15=Shaik |first15=Riyazuddin Mohammad |date=September 2021 |title=mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar |url=https://www.nature.com/articles/s41591-021-01446-y |journal=Nature Medicine |language=en |volume=27 |issue=9 |pages=1614–1621 |doi=10.1038/s41591-021-01446-y |issn=1546-170X}}</ref><ref>{{Cite journal |last=Tang |first=Patrick |last2=Hasan |first2=Mohammad R. |last3=Chemaitelly |first3=Hiam |last4=Yassine |first4=Hadi M. |last5=Benslimane |first5=Fatiha M. |last6=Al Khatib |first6=Hebah A. |last7=AlMukdad |first7=Sawsan |last8=Coyle |first8=Peter |last9=Ayoub |first9=Houssein H. |last10=Al Kanaani |first10=Zaina |last11=Al Kuwari |first11=Einas |last12=Jeremijenko |first12=Andrew |last13=Kaleeckal |first13=Anvar Hassan |last14=Latif |first14=Ali Nizar |last15=Shaik |first15=Riyazuddin Mohammad |date=December 2021 |title=BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar |url=https://www.nature.com/articles/s41591-021-01583-4 |journal=Nature Medicine |language=en |volume=27 |issue=12 |pages=2136–2143 |doi=10.1038/s41591-021-01583-4 |issn=1546-170X}}</ref><ref>{{Cite journal |last=Younes |first=Nadin |last2=Al-Sadeq |first2=Duaa W. |last3=AL-Jighefee |first3=Hadeel |last4=Younes |first4=Salma |last5=Al-Jamal |first5=Ola |last6=Daas |first6=Hanin I. |last7=Yassine |first7=Hadi M. |last8=Nasrallah |first8=Gheyath K. |date=June 2020 |title=Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 |url=https://www.mdpi.com/1999-4915/12/6/582 |journal=Viruses |language=en |volume=12 |issue=6 |pages=582 |doi=10.3390/v12060582 |issn=1999-4915}}</ref><ref>{{Cite journal |last=Chemaitelly |first=Hiam |last2=Tang |first2=Patrick |last3=Hasan |first3=Mohammad R. |last4=AlMukdad |first4=Sawsan |last5=Yassine |first5=Hadi M. |last6=Benslimane |first6=Fatiha M. |last7=Al Khatib |first7=Hebah A. |last8=Coyle |first8=Peter |last9=Ayoub |first9=Houssein H. |last10=Al Kanaani |first10=Zaina |last11=Al Kuwari |first11=Einas |last12=Jeremijenko |first12=Andrew |last13=Kaleeckal |first13=Anvar H. |last14=Latif |first14=Ali N. |last15=Shaik |first15=Riyazuddin M. |date=2021-12-09 |title=Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar |url=http://www.nejm.org/doi/10.1056/NEJMoa2114114 |journal=New England Journal of Medicine |language=en |volume=385 |issue=24 |pages=e83 |doi=10.1056/NEJMoa2114114 |issn=0028-4793 |pmc=PMC8522799 |pmid=34614327}}</ref><ref>{{Cite journal |last=Abu-Raddad |first=Laith J. |last2=Chemaitelly |first2=Hiam |last3=Butt |first3=Adeel A. |date=2021-07-08 |title=Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |url=http://www.nejm.org/doi/10.1056/NEJMc2104974 |journal=New England Journal of Medicine |language=en |volume=385 |issue=2 |pages=187–189 |doi=10.1056/NEJMc2104974 |issn=0028-4793 |pmc=PMC8117967 |pmid=33951357}}</ref><ref name=":5">{{Cite web |title=(BRC)- (QU) CONDUCTS SIX RESEARCH PROJECTS ON COVID-19 |url=http://www.qu.edu.qa/newsroom/BRC/(BRC)%E2%80%93-(QU)-conducts-six-researches-on-COVID%E2%80%9319 |access-date=2020-03-28 |website=www.qu.edu.qa}}</ref><ref name=":6">{{Cite web |last=Newspaper |first=The Peninsula |date=2020-03-29 |title=Qatar University’s Biomedical Research Center conducting research on COVID-19 |url=https://thepeninsulaqatar.com/article/29/03/2020/Qatar-University%E2%80%99s-Biomedical-Research-Center-conducting-research-on-COVID-19 |access-date= |website=thepeninsulaqatar.com |language=en}}</ref><ref name=":0">{{Cite web |date=2020-03-28 |title=Qatar- QU conducts research on coronavirus {{!}} MENAFN.COM |url=https://menafn.com/1099929849/Qatar-QU-conducts-research-on-coronavirus |access-date= |website=menafn.com}}</ref> to assist in fighting and recovery.
* Conducted six research on [[COVID-19]]<ref>{{cite journal | vauthors = Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M, Yang ZY, Chen X, Becker MM, Freeman M, Vogel L, Johnson JC, Olinger G, Todd JP, Bagci U, Solomon J, Mollura DJ, Hensley L, Jahrling P, Denison MR, Rao SS, Subbarao K, Kwong PD, Mascola JR, Kong WP, Graham BS | display-authors = 6 | title = Evaluation of candidate vaccine approaches for MERS-CoV | journal = Nature Communications | volume = 6 | issue = 1 | pages = 7712 | date = July 2015 | pmid = 26218507 | doi = 10.1038/ncomms8712 }}</ref><ref>{{cite journal | vauthors = Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, Malek JA, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Butt AA, Bertollini R, Abu-Raddad LJ | display-authors = 6 | title = mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | journal = Nature Medicine | volume = 27 | issue = 9 | pages = 1614–1621 | date = September 2021 | pmid = 34244681 | doi = 10.1038/s41591-021-01446-y }}</ref><ref>{{cite journal | vauthors = Tang P, Hasan MR, Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, AlMukdad S, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Butt AA, Al-Thani MH, Al Khal A, Bertollini R, Abu-Raddad LJ | display-authors = 6 | title = BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar | journal = Nature Medicine | volume = 27 | issue = 12 | pages = 2136–2143 | date = December 2021 | pmid = 34728831 | doi = 10.1038/s41591-021-01583-4 }}</ref><ref>{{cite journal | vauthors = Younes N, Al-Sadeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, Yassine HM, Nasrallah GK | display-authors = 6 | title = Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 | journal = Viruses | volume = 12 | issue = 6 | pages = 582 | date = May 2020 | pmid = 32466458 | doi = 10.3390/v12060582 }}</ref><ref>{{cite journal | vauthors = Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, Al Khatib HA, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Butt AA, Al-Thani MH, Al Khal A, Bertollini R, Abu-Raddad LJ | display-authors = 6 | title = Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | journal = The New England Journal of Medicine | volume = 385 | issue = 24 | pages = e83 | date = December 2021 | pmid = 34614327 | pmc = 8522799 | doi = 10.1056/NEJMoa2114114 }}</ref><ref>{{cite journal | vauthors = Abu-Raddad LJ, Chemaitelly H, Butt AA | title = Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants | journal = The New England Journal of Medicine | volume = 385 | issue = 2 | pages = 187–189 | date = July 2021 | pmid = 33951357 | pmc = 8117967 | doi = 10.1056/NEJMc2104974 }}</ref><ref name=":5">{{Cite web |title=(BRC)- (QU) CONDUCTS SIX RESEARCH PROJECTS ON COVID-19 |url=http://www.qu.edu.qa/newsroom/BRC/(BRC)%E2%80%93-(QU)-conducts-six-researches-on-COVID%E2%80%9319 |access-date=2020-03-28 |website=www.qu.edu.qa}}</ref><ref name=":6">{{Cite web | work = The Peninsula Newspaper |date=2020-03-29 |title=Qatar University’s Biomedical Research Center conducting research on COVID-19 |url=https://thepeninsulaqatar.com/article/29/03/2020/Qatar-University%E2%80%99s-Biomedical-Research-Center-conducting-research-on-COVID-19 |language=en}}</ref><ref name=":0">{{Cite web |date=2020-03-28 |title=Qatar- QU conducts research on coronavirus | work =MENAFN.COM |url=https://menafn.com/1099929849/Qatar-QU-conducts-research-on-coronavirus }}</ref> to assist in fighting and recovery.
* Provided a study on protection against the [[SARS-CoV-2 Omicron variant|Omicron variant]] in Qatar.<ref>{{Cite journal |last=Altarawneh |first=Heba N. |last2=Chemaitelly |first2=Hiam |last3=Hasan |first3=Mohammad R. |last4=Ayoub |first4=Houssein H. |last5=Qassim |first5=Suelen |last6=AlMukdad |first6=Sawsan |last7=Coyle |first7=Peter |last8=Yassine |first8=Hadi M. |last9=Al-Khatib |first9=Hebah A. |last10=Benslimane |first10=Fatiha M. |last11=Al-Kanaani |first11=Zaina |last12=Al-Kuwari |first12=Einas |last13=Jeremijenko |first13=Andrew |last14=Kaleeckal |first14=Anvar H. |last15=Latif |first15=Ali N. |date=2022-03-31 |title=Protection against the Omicron Variant from Previous SARS-CoV-2 Infection |url=http://www.nejm.org/doi/10.1056/NEJMc2200133 |journal=New England Journal of Medicine |language=en |volume=386 |issue=13 |pages=1288–1290 |doi=10.1056/NEJMc2200133 |issn=0028-4793 |pmc=PMC8849180 |pmid=35139269}}</ref><ref>{{Cite journal |last=Abu-Raddad |first=Laith J. |last2=Chemaitelly |first2=Hiam |last3=Ayoub |first3=Houssein H. |last4=AlMukdad |first4=Sawsan |last5=Yassine |first5=Hadi M. |last6=Al-Khatib |first6=Hebah A. |last7=Smatti |first7=Maria K. |last8=Tang |first8=Patrick |last9=Hasan |first9=Mohammad R. |last10=Coyle |first10=Peter |last11=Al-Kanaani |first11=Zaina |last12=Al-Kuwari |first12=Einas |last13=Jeremijenko |first13=Andrew |last14=Kaleeckal |first14=Anvar H. |last15=Latif |first15=Ali N. |date=2022-05-12 |title=Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar |url=http://www.nejm.org/doi/10.1056/NEJMoa2200797 |journal=New England Journal of Medicine |language=en |volume=386 |issue=19 |pages=1804–1816 |doi=10.1056/NEJMoa2200797 |issn=0028-4793 |pmc=PMC8929389 |pmid=35263534}}</ref><ref>{{Cite journal |last=Altarawneh |first=Heba N. |last2=Chemaitelly |first2=Hiam |last3=Ayoub |first3=Houssein H. |last4=Tang |first4=Patrick |last5=Hasan |first5=Mohammad R. |last6=Yassine |first6=Hadi M. |last7=Al-Khatib |first7=Hebah A. |last8=Smatti |first8=Maria K. |last9=Coyle |first9=Peter |last10=Al-Kanaani |first10=Zaina |last11=Al-Kuwari |first11=Einas |last12=Jeremijenko |first12=Andrew |last13=Kaleeckal |first13=Anvar H. |last14=Latif |first14=Ali N. |last15=Shaik |first15=Riyazuddin M. |date=2022-07-07 |title=Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections |url=http://www.nejm.org/doi/10.1056/NEJMoa2203965 |journal=New England Journal of Medicine |language=en |volume=387 |issue=1 |pages=21–34 |doi=10.1056/NEJMoa2203965 |issn=0028-4793 |pmc=PMC9258753 |pmid=35704396}}</ref>
* Provided a study on protection against the [[SARS-CoV-2 Omicron variant|Omicron variant]] in Qatar.<ref>{{cite journal | vauthors = Altarawneh HN, Chemaitelly H, Hasan MR, Ayoub HH, Qassim S, AlMukdad S, Coyle P, Yassine HM, Al-Khatib HA, Benslimane FM, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Tang P, Abu-Raddad LJ | display-authors = 6 | title = Protection against the Omicron Variant from Previous SARS-CoV-2 Infection | journal = The New England Journal of Medicine | volume = 386 | issue = 13 | pages = 1288–1290 | date = March 2022 | pmid = 35139269 | pmc = 8849180 | doi = 10.1056/NEJMc2200133 }}</ref><ref>{{cite journal | vauthors = Abu-Raddad LJ, Chemaitelly H, Ayoub HH, AlMukdad S, Yassine HM, Al-Khatib HA, Smatti MK, Tang P, Hasan MR, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R | display-authors = 6 | title = Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | journal = The New England Journal of Medicine | volume = 386 | issue = 19 | pages = 1804–1816 | date = May 2022 | pmid = 35263534 | pmc = 8929389 | doi = 10.1056/NEJMoa2200797 }}</ref><ref>{{cite journal | vauthors = Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, Al-Khatib HA, Smatti MK, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ | display-authors = 6 | title = Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | journal = The New England Journal of Medicine | volume = 387 | issue = 1 | pages = 21–34 | date = July 2022 | pmid = 35704396 | pmc = 9258753 | doi = 10.1056/NEJMoa2203965 }}</ref>
* Decoded the [[genetic code]] of Qatari [[Falcon|falcons]]<ref name=":6" /><ref name=":0" /> and various endangered animal species.<ref name=":2">{{Cite web |date=2020-11-27 |title=Qatar- QUBRC records rapid growth in published medical resea... {{!}} MENAFN.COM |url=https://menafn.com/1101197136/Qatar-QUBRC-records-rapid-growth-in-published-medical-research |access-date= |website=menafn.com}}</ref>
* Decoded the [[genetic code]] of Qatari [[Falcon|falcons]]<ref name=":6" /><ref name=":0" /> and various endangered animal species.<ref name=":2">{{Cite web |date=2020-11-27 |title=Qatar- QUBRC records rapid growth in published medical resea... {{!}} MENAFN.COM |url=https://menafn.com/1101197136/Qatar-QUBRC-records-rapid-growth-in-published-medical-research |access-date= |website=menafn.com}}</ref>
* [[DNA sequencing|DNA sequence]] of the [[Dugong]] (sea cow).<ref name=":6" /><ref name=":0" />
* [[DNA sequencing|DNA sequence]] of the [[Dugong]] (sea cow).<ref name=":6" /><ref name=":0" />
* Study a [[nanomedicine]]-based preventative strategy to controlling diseases and improve health.<ref>{{Cite web |date=February 2023 |title=Nanomedicine as a Potential Tool against Monkeypox |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85149215008&origin=resultslist&sort=plf-f |access-date= |website=www.scopus.com}}</ref><ref>{{Cite web |date=July 2022 |title=Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2 |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85135132656&origin=resultslist&sort=plf-f |access-date= |website=www.scopus.com}}</ref><ref>{{Cite web |date=February 2022 |title=Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85123318369&origin=resultslist&sort=plf-f}}</ref>
* Study a [[nanomedicine]]-based preventative strategy to controlling diseases and improve health.<ref name="pmid36851305">{{cite journal | vauthors = Mohamed NA, Zupin L, Mazi SI, Al-Khatib HA, Crovella S | title = Nanomedicine as a Potential Tool against Monkeypox | journal = Vaccines | volume = 11 | issue = 2 | pages = | date = February 2023 | pmid = 36851305 | pmc = 9963669 | doi = 10.3390/vaccines11020428 }}</ref><ref name="pmid35891532">{{cite journal | vauthors = Mohamed NA, Abou-Saleh H, Mohamed HA, Al-Ghouti MA, Crovella S, Zupin L | title = Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2 | journal = Viruses | volume = 14 | issue = 7 | pages = | date = July 2022 | pmid = 35891532 | pmc = 9318803 | doi = 10.3390/v14071553 }}</ref><ref name="pmid35163328">{{cite journal | vauthors = Mohamed NA, Marei I, Crovella S, Abou-Saleh H | title = Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases | journal = International Journal of Molecular Sciences | volume = 23 | issue = 3 | pages = | date = January 2022 | pmid = 35163328 | pmc = 8836006 | doi = 10.3390/ijms23031404 }}</ref>


== Zebrafish Research Model ==
== Zebrafish Research Model ==
[[File:Zebrafish_Graphics_from_Qatar_University.jpg|alt=BRC Introduced the use of zebrafish as an animal model in biomedical research at Qatar University|thumb|BRC Introduced the use of zebrafish as an animal model in biomedical research at Qatar University]]
[[File:Zebrafish_Graphics_from_Qatar_University.jpg|alt=BRC Introduced the use of zebrafish as an animal model in biomedical research at Qatar University|thumb|BRC Introduced the use of zebrafish as an animal model in biomedical research at Qatar University]]
BRC Introduced the use of [[Zebrafish]] as an animal model in biomedical research<ref>{{Cite journal |last=Zakaria |first=Zain Z. |last2=Benslimane |first2=Fatiha M. |last3=Nasrallah |first3=Gheyath K. |last4=Shurbaji |first4=Samar |last5=Younes |first5=Nadin N. |last6=Mraiche |first6=Fatima |last7=Da’as |first7=Sahar I. |last8=Yalcin |first8=Huseyin C. |date=2018-09-27 |title=Using Zebrafish for Investigating the Molecular Mechanisms of Drug-Induced Cardiotoxicity |url=http://dx.doi.org/10.1155/2018/1642684 |journal=BioMed Research International |volume=2018 |pages=1–10 |doi=10.1155/2018/1642684 |issn=2314-6133}}</ref><ref>{{Cite web |date=2019-10-01 |title=The First International Zebrafish Conference/Workshop in Qatar |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85072686786&origin=resultslist&sort=plf-f |access-date= |website=www.scopus.com}}</ref><ref name=":2" /><ref>{{Cite web |date=August 2021 |title=Utilization Of Zebrafish As An Animal Model {{!}} Qatar University |url=http://www.qu.edu.qa/research/brc/Training/basic-training-on-utilization-of-zebrafish-as-an-animal-model |access-date= |website=www.qu.edu.qa}}</ref><ref>{{Cite web |date=April 2017 |title=Qatar International Zebrafish Workshop {{!}} Qatar University |url=http://www.qu.edu.qa/conference/zebrafish-workshop |access-date= |website=www.qu.edu.qa}}</ref><ref>{{Cite web |last=Newspaper |first=The Peninsula |date=2019-04-20 |title=Qatar University workshop introduces ‘zebrafish model’ research |url=https://thepeninsulaqatar.com/article/20/04/2019/Qatar-University-workshop-introduces-%E2%80%98zebrafish-model%E2%80%99-research |access-date= |website=thepeninsulaqatar.com |language=en}}</ref> at QU and established for it a facility<ref name=":7">{{Cite web |date=2023 |title=Facilities {{!}} Qatar University |url=http://www.qu.edu.qa/research/brc/facilities |access-date= |website=www.qu.edu.qa}}</ref> in 2015.<ref name=":3">{{Cite web |date=2019-04-14 |title=QU PAVES THE WAY IN RESEARCH THROUGH ZEBRAFISH |url=http://www.qu.edu.qa/newsroom/Research/QU-paves-the-way-in-research-through-Zebrafish |access-date= |website=www.qu.edu.qa}}</ref><ref>{{Cite web |date=2019 |title=The First International Zebrafish Conference/Workshop in Qatar {{!}} IZFS - International Zebrafish Society |url=https://www.izfs.org/newssplash/newssplash-issue-7-fall-2019/the-first-international-zebrafish-conferenceworkshop-in-qatar |access-date= |website=www.izfs.org}}</ref> The facility is used as a research unit to study many genetic diseases.<ref name=":2" /> Therefore, [[Ministry of Public Health (Qatar)]] clearly articulated an institutional research policy (IRP) on human use of Zebrafish in research,<ref name=":8">{{Cite web |date=2020 |title=Policy on Zebrafish Research, Ministry of Public Health, Department of Research Regulation |url=http://www.qu.edu.qa/static_file/qu/research/documents/qu_iacuc/Policy%20on%20Zebrafish%20Research.pdf |url-status=live |access-date=}}</ref> and QU circulated it to QU community for implementation.
BRC Introduced the use of [[Zebrafish]] as an animal model in biomedical research<ref>{{cite journal | vauthors = Zakaria ZZ, Benslimane FM, Nasrallah GK, Shurbaji S, Younes NN, Mraiche F, Da'as SI, Yalcin HC | display-authors = 6 | title = Using Zebrafish for Investigating the Molecular Mechanisms of Drug-Induced Cardiotoxicity | journal = BioMed Research International | volume = 2018 | pages = 1642684 | date = 2018-09-27 | pmid = 30363733 | doi = 10.1155/2018/1642684 }}</ref><ref name="pmid31453757">{{cite journal | vauthors = Yalcin HC, Benslimane FM, Kawakami K | title = The First International Zebrafish Conference/Workshop in Qatar | journal = Zebrafish | volume = 16 | issue = 5 | pages = 493–495 | date = October 2019 | pmid = 31453757 | doi = 10.1089/zeb.2019.1786 }}</ref><ref name=":2" /><ref>{{Cite web |date=August 2021 |title=Utilization Of Zebrafish As An Animal Model | work = Qatar University |url=http://www.qu.edu.qa/research/brc/Training/basic-training-on-utilization-of-zebrafish-as-an-animal-model |access-date= }}</ref><ref>{{Cite web |date=April 2017 |title=Qatar International Zebrafish Workshop | work = Qatar University |url=http://www.qu.edu.qa/conference/zebrafish-workshop }}</ref><ref>{{Cite web | work = The Peninsula Newspaper|date=2019-04-20 |title=Qatar University workshop introduces ‘zebrafish model’ research |url=https://thepeninsulaqatar.com/article/20/04/2019/Qatar-University-workshop-introduces-%E2%80%98zebrafish-model%E2%80%99-research |language=en}}</ref> at QU and established for it a facility<ref name=":7">{{Cite web |date=2023 |title=Facilities | work = Qatar University |url=http://www.qu.edu.qa/research/brc/facilities }}</ref> in 2015.<ref name=":3">{{Cite web |date=2019-04-14 |title=QU Paves the Way in Research in Zebra Fish |url=http://www.qu.edu.qa/newsroom/Research/QU-paves-the-way-in-research-through-Zebrafish |access-date= |website=www.qu.edu.qa}}</ref><ref>{{Cite web |date=2019 |title=The First International Zebrafish Conference/Workshop in Qatar {{!}} IZFS - International Zebrafish Society |url=https://www.izfs.org/newssplash/newssplash-issue-7-fall-2019/the-first-international-zebrafish-conferenceworkshop-in-qatar |access-date= |website=www.izfs.org}}</ref> The facility is used as a research unit to study many genetic diseases.<ref name=":2" /> Therefore, [[Ministry of Public Health (Qatar)]] clearly articulated an institutional research policy (IRP) on human use of Zebrafish in research,<ref name=":8">{{Cite web |date=2020 |title=Policy on Zebrafish Research, Ministry of Public Health, Department of Research Regulation |url=http://www.qu.edu.qa/static_file/qu/research/documents/qu_iacuc/Policy%20on%20Zebrafish%20Research.pdf |url-status=live |access-date=}}</ref> and QU circulated it to QU community for implementation.


The following advantages make Zebrafish an ideal animal model for biomedical research:
The following advantages make Zebrafish an ideal animal model for biomedical research:
Line 70: Line 70:


* Zebrafish aquatic system
* Zebrafish aquatic system
* [[Biosafety level]] 3 (BSL3)<ref name=":4" /><ref name=":0" /><ref name=":2" /> built by CERTEK,<ref>{{Cite web |title=Certek, biosafety laboratory, custom built modular laboratories, modular laboratory, biosafety, BSL-3 |url=https://certek-usa.com/clientele/clientele-list/ |access-date=2023-03-15 |website=CERTEK |language=en}}</ref> USA. It is equipped for viral- and bacterial research on risk group 3 [[Pathogen|pathogens]].<ref>{{Cite web |date=June 2021 |title=Profiling of intestinal microbiota in patients infected with respiratory influenza a and b viruses |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85108995451&origin=resultslist&sort=plf-f |access-date= |website=www.scopus.com}}</ref>
* [[Biosafety level]] 3 (BSL3)<ref name=":4" /><ref name=":0" /><ref name=":2" /> built by CERTEK,<ref>{{Cite web |title=Certek, biosafety laboratory, custom built modular laboratories, modular laboratory, biosafety, BSL-3 |url=https://certek-usa.com/clientele/clientele-list/ |access-date=2023-03-15 |website=CERTEK |language=en}}</ref> USA. It is equipped for viral- and bacterial research on risk group 3 [[Pathogen|pathogens]].<ref name="pmid34204203">{{cite journal | vauthors = Al Khatib HA, Mathew S, Smatti MK, Eltai NO, Pathan SA, Al Thani AA, Coyle PV, Al Maslamani MA, Yassine HM | display-authors = 6 | title = Profiling of Intestinal Microbiota in Patients Infected with Respiratory Influenza A and B Viruses | journal = Pathogens | volume = 10 | issue = 6 | date = June 2021 | pmid = 34204203 | pmc = 8233933 | doi = 10.3390/pathogens10060761 }}</ref>
* Sequencing unit to conduct state-of-the-art research in [[genomics]].<ref>{{Cite web |date=August 2021 |title=Whole-genome sequencing for molecular characterization of carbapenem-resistant enterobacteriaceae causing lower urinary tract infection among pediatric patients |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85113738683&origin=resultslist&sort=plf-f&src=s&st1=Whole-genome+sequencing+for+molecular+characterization+of+carbapenem-resistant+enterobacteriaceae+causing+lower+urinary+tract+infection+among+pediatric+patients&sid=00786a09e4d1b906e9933307d3f70eca&sot=b&sdt=b&sl=165&s=ALL%28Whole-genome+sequencing+for+molecular+characterization+of+carbapenem-resistant+enterobacteriaceae+causing+lower+urinary+tract+infection+among+pediatric+patients%29&relpos=15&citeCnt=6&searchTerm= |access-date= |website=www.scopus.com}}</ref><ref>{{Cite web |date=2021 |title=Whole genome sequencing of marine organisms by Oxford Nanopore Technologies: Assessment and optimization of HMW-DNA extraction protocols |url=https://www.scopus.com/record/display.uri?eid=2-s2.0-85120687096&origin=resultslist&sort=plf-f |access-date= |website=www.scopus.com}}</ref>
* Sequencing unit to conduct state-of-the-art research in [[genomics]].<ref name="pmid34439022">{{cite journal | vauthors = Al Mana H, Sundararaju S, Tsui CK, Perez-Lopez A, Yassine H, Al Thani A, Al-Ansari K, Eltai NO | display-authors = 6 | title = Whole-Genome Sequencing for Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae Causing Lower Urinary Tract Infection among Pediatric Patients | journal = Antibiotics | volume = 10 | issue = 8 | date = August 2021 | pmid = 34439022 | pmc = 8388976 | doi = 10.3390/antibiotics10080972 }}</ref><ref name="pmid35003688">{{cite journal | vauthors = Boughattas S, Albatesh D, Al-Khater A, Giraldes BW, Althani AA, Benslimane FM | title = Whole genome sequencing of marine organisms by Oxford Nanopore Technologies: Assessment and optimization of HMW-DNA extraction protocols | journal = Ecology and Evolution | volume = 11 | issue = 24 | pages = 18505–18513 | date = December 2021 | pmid = 35003688 | pmc = 8717308 | doi = 10.1002/ece3.8447 | url = }}</ref>


== Future Endeavors ==
== Future Endeavors ==

Revision as of 12:02, 15 March 2023

Biomedical Research Center
Biomedical Research Center
مركز البحوث الحيوية الطبية
AbbreviationBRC
Formation2014
HeadquartersQatar University
Location
Region
Middle East
ServicesResearch and Education
FieldsBiomedical science
Official language
Arabic and English
Websitehttp://www.qu.edu.qa/research/brc

The Biomedical Research Center (BRC) is a research center at Qatar University focusing on biomedical research. BRC was founded in 2014, and partners with the Ministry of Public Health (Qatar), and Hamad Medical Corporation (HMC).[1][2][3]

Background

The incidence of genetic disorders in Qatar is high.[4]. Qatar's top three causes of death are cancer, heart diseases and diabetes.[5][6] The government saw the creation of BRC as a strategy for proactively preventing diseases, to foster public health.[7] In this context, having an advanced, world-class research center in health and biomedical sciences is indispensable for Qatar.[8]

Accreditation

BRC labs received the ISO/IEC - 17025 accreditation from the American Association for Laboratory Accreditation (A2LA),[9] which reflects their commitments to high-quality research standards.        

Areas of Research Focus

BRC cultivated highly productive research focused on the following domains:[10]

Research with Impact

photo of Qatar’s dugongs
Qatar’s dugongs

Since its inauguration in 2014, BRC research[11] outcome curve shows tremendous achievement in the number of published research papers with more than 530 publications.[12]

The following are some of research projects that demonstrate BRC commitment to research that is tackling the national problems, and beyond:

Zebrafish Research Model

BRC Introduced the use of zebrafish as an animal model in biomedical research at Qatar University
BRC Introduced the use of zebrafish as an animal model in biomedical research at Qatar University

BRC Introduced the use of Zebrafish as an animal model in biomedical research[36][37][32][38][39][40] at QU and established for it a facility[41] in 2015.[42][43] The facility is used as a research unit to study many genetic diseases.[32] Therefore, Ministry of Public Health (Qatar) clearly articulated an institutional research policy (IRP) on human use of Zebrafish in research,[44] and QU circulated it to QU community for implementation.

The following advantages make Zebrafish an ideal animal model for biomedical research:

  • Zebrafish genes are similar to human genes,[45] thus a good predictive model for human development and diseases.[44]
  • Zebrafish can spawn hundreds of embryos a week[46] and this allows statistically significant analyses at a minimal cost.[44]
  • Embryos are transparent[47] and that make them ideal for microscopic imaging of life processes.[44]
  • Embryos are simple and develop externally to the mother and grow to maturity within a 2-3 month, thus can be viewed and manipulated seamlessly.[47]

BRC Facilities

Biosafety level 3 (BSL3) lab at BRC, Qatar University

The BRC has many world-class facilites[41] and equipped with the state-of-the-art technologies. The following facilities are the most notable:

Future Endeavors

  • Leverage QU interdisciplinary status.[2]
  • Develop scientific research on communicable and non-communicable diseases.[26]
  • Increase research outputs of high impact with focus in areas of national needs.[52]
  • Extend collaboration in research, services and education outreach.[53]

See Also

References

  1. ^ "BRC AND SCH SIGN COLLABORATIVE AGREEMENT". www.qu.edu.qa. 2015-11-05.
  2. ^ a b "Biomedical Research Center | Qatar University". www.qu.edu.qa. 2023.
  3. ^ "Qatar puts the pursuit of knowledge front and centre". 2023.
  4. ^ "Research | Qatar Genome Programme". www.qatargenome.org.qa. 2023.
  5. ^ "Qatar". Institute for Health Metrics and Evaluation. 2015-09-09.
  6. ^ "Health and Biomedical Sciences | Qatar University". www.qu.edu.qa. 2020-10-19.
  7. ^ "Qatar National Vision 2030 | General Secretariat For Development Planning" (PDF). July 2008.
  8. ^ "Research Pillars and Priorities | Qatar University". www.qu.edu.qa. 2020-10-19.
  9. ^ "QU BIOMEDICAL RESEARCH CENTER AND LABORATORY ANIMAL RESEARCH CENTER AWARDED ISO IEC - 17025 ACCREDITATION". www.qu.edu.qa. 2018-07-01.
  10. ^ "Divisions and Researches | Qatar University". www.qu.edu.qa. Retrieved 2023-03-14.
  11. ^ "BRC Publications | Qatar University". www.qu.edu.qa. 2022-02-24.
  12. ^ "Qatar University Institutional Repository | Biomedical Research Center". qspace.qu.edu.qa. 2023.
  13. ^ El Zowalaty ME, Al Thani AA, Webster TJ, El Zowalaty AE, Schweizer HP, Nasrallah GK, et al. (2015-10-01). "Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies". Future Microbiology. 10 (10): 1683–1706. doi:10.2217/fmb.15.48. PMID 26439366.
  14. ^ Johar AR, Abu-Rub LI, Al Mana H, Yassine HM, Eltai NO (September 2022). "Microbiome engineering to combat antimicrobial resistance and upsurge productivity of food animals: a systematic review". Animal Production Science. doi:10.1071/AN22233.
  15. ^ Eltai NO, Yassine HM, Al Thani AA, Abu Madi MA, Ismail A, Ibrahim E, Alali WQ (2018). "Prevalence of antibiotic resistant Escherichia coli isolates from fecal samples of food handlers in Qatar". Antimicrobial Resistance and Infection Control. 7: 78. doi:10.1186/s13756-018-0369-2. PMC 6019201. PMID 29983931.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  16. ^ Al-Hadidi SH, Al Mana H, Almoghrabi SZ, El-Obeid T, AlAli WQ, Eltai NO (July 2022). "Retail Chicken Carcasses as a Reservoir of Multidrug-Resistant Salmonella". Microbial Drug Resistance. 28 (7). Larchmont, N.Y.: 824–831. doi:10.1089/mdr.2021.0414. PMC 9347385. PMID 35675669.
  17. ^ a b "Qatar University's Biomedical Research Center conducting research on COVID-19". The Peninsula Newspaper. 2020-03-29. Retrieved 2023-03-14.
  18. ^ Al-Sulaiti H, Diboun I, Agha MV, Mohamed FF, Atkin S, Dömling AS, et al. (October 2019). "Metabolic signature of obesity-associated insulin resistance and type 2 diabetes". Journal of Translational Medicine. 17 (1): 348. doi:10.1186/s12967-019-2096-8. PMC 6805293. PMID 31640727.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  19. ^ "WCM-Q research probes causal link between obesity and diabetes". Latest News - Weill Cornell Medicine - Qatar. December 2019.
  20. ^ Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, et al. (July 2015). "Evaluation of candidate vaccine approaches for MERS-CoV". Nature Communications. 6 (1): 7712. doi:10.1038/ncomms8712. PMID 26218507.
  21. ^ Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, et al. (September 2021). "mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar". Nature Medicine. 27 (9): 1614–1621. doi:10.1038/s41591-021-01446-y. PMID 34244681.
  22. ^ Tang P, Hasan MR, Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, et al. (December 2021). "BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar". Nature Medicine. 27 (12): 2136–2143. doi:10.1038/s41591-021-01583-4. PMID 34728831.
  23. ^ Younes N, Al-Sadeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, et al. (May 2020). "Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2". Viruses. 12 (6): 582. doi:10.3390/v12060582. PMID 32466458.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  24. ^ Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, et al. (December 2021). "Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar". The New England Journal of Medicine. 385 (24): e83. doi:10.1056/NEJMoa2114114. PMC 8522799. PMID 34614327.
  25. ^ Abu-Raddad LJ, Chemaitelly H, Butt AA (July 2021). "Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants". The New England Journal of Medicine. 385 (2): 187–189. doi:10.1056/NEJMc2104974. PMC 8117967. PMID 33951357.
  26. ^ a b "(BRC)- (QU) CONDUCTS SIX RESEARCH PROJECTS ON COVID-19". www.qu.edu.qa. Retrieved 2020-03-28.
  27. ^ a b c "Qatar University's Biomedical Research Center conducting research on COVID-19". The Peninsula Newspaper. 2020-03-29.
  28. ^ a b c d "Qatar- QU conducts research on coronavirus". MENAFN.COM. 2020-03-28.
  29. ^ Altarawneh HN, Chemaitelly H, Hasan MR, Ayoub HH, Qassim S, AlMukdad S, et al. (March 2022). "Protection against the Omicron Variant from Previous SARS-CoV-2 Infection". The New England Journal of Medicine. 386 (13): 1288–1290. doi:10.1056/NEJMc2200133. PMC 8849180. PMID 35139269.
  30. ^ Abu-Raddad LJ, Chemaitelly H, Ayoub HH, AlMukdad S, Yassine HM, Al-Khatib HA, et al. (May 2022). "Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar". The New England Journal of Medicine. 386 (19): 1804–1816. doi:10.1056/NEJMoa2200797. PMC 8929389. PMID 35263534.
  31. ^ Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, et al. (July 2022). "Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections". The New England Journal of Medicine. 387 (1): 21–34. doi:10.1056/NEJMoa2203965. PMC 9258753. PMID 35704396.
  32. ^ a b c d "Qatar- QUBRC records rapid growth in published medical resea... | MENAFN.COM". menafn.com. 2020-11-27.
  33. ^ Mohamed NA, Zupin L, Mazi SI, Al-Khatib HA, Crovella S (February 2023). "Nanomedicine as a Potential Tool against Monkeypox". Vaccines. 11 (2). doi:10.3390/vaccines11020428. PMC 9963669. PMID 36851305.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  34. ^ Mohamed NA, Abou-Saleh H, Mohamed HA, Al-Ghouti MA, Crovella S, Zupin L (July 2022). "Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2". Viruses. 14 (7). doi:10.3390/v14071553. PMC 9318803. PMID 35891532.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  35. ^ Mohamed NA, Marei I, Crovella S, Abou-Saleh H (January 2022). "Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases". International Journal of Molecular Sciences. 23 (3). doi:10.3390/ijms23031404. PMC 8836006. PMID 35163328.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  36. ^ Zakaria ZZ, Benslimane FM, Nasrallah GK, Shurbaji S, Younes NN, Mraiche F, et al. (2018-09-27). "Using Zebrafish for Investigating the Molecular Mechanisms of Drug-Induced Cardiotoxicity". BioMed Research International. 2018: 1642684. doi:10.1155/2018/1642684. PMID 30363733.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  37. ^ Yalcin HC, Benslimane FM, Kawakami K (October 2019). "The First International Zebrafish Conference/Workshop in Qatar". Zebrafish. 16 (5): 493–495. doi:10.1089/zeb.2019.1786. PMID 31453757.
  38. ^ "Utilization Of Zebrafish As An Animal Model". Qatar University. August 2021.
  39. ^ "Qatar International Zebrafish Workshop". Qatar University. April 2017.
  40. ^ "Qatar University workshop introduces 'zebrafish model' research". The Peninsula Newspaper. 2019-04-20.
  41. ^ a b "Facilities". Qatar University. 2023.
  42. ^ "QU Paves the Way in Research in Zebra Fish". www.qu.edu.qa. 2019-04-14.
  43. ^ "The First International Zebrafish Conference/Workshop in Qatar | IZFS - International Zebrafish Society". www.izfs.org. 2019.
  44. ^ a b c d "Policy on Zebrafish Research, Ministry of Public Health, Department of Research Regulation" (PDF). 2020.{{cite web}}: CS1 maint: url-status (link)
  45. ^ "QU conference focuses on use of zebrafish as research tool". Gulf Times. 2019-04-20.
  46. ^ "Zebrafish embryos - 24-hours-old". Come See Our World. 2023.
  47. ^ a b "Zebrafish". University of Cambridge. 2016-10-28.
  48. ^ "Certek, biosafety laboratory, custom built modular laboratories, modular laboratory, biosafety, BSL-3". CERTEK. Retrieved 2023-03-15.
  49. ^ Al Khatib HA, Mathew S, Smatti MK, Eltai NO, Pathan SA, Al Thani AA, et al. (June 2021). "Profiling of Intestinal Microbiota in Patients Infected with Respiratory Influenza A and B Viruses". Pathogens. 10 (6). doi:10.3390/pathogens10060761. PMC 8233933. PMID 34204203.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  50. ^ Al Mana H, Sundararaju S, Tsui CK, Perez-Lopez A, Yassine H, Al Thani A, et al. (August 2021). "Whole-Genome Sequencing for Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae Causing Lower Urinary Tract Infection among Pediatric Patients". Antibiotics. 10 (8). doi:10.3390/antibiotics10080972. PMC 8388976. PMID 34439022.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  51. ^ Boughattas S, Albatesh D, Al-Khater A, Giraldes BW, Althani AA, Benslimane FM (December 2021). "Whole genome sequencing of marine organisms by Oxford Nanopore Technologies: Assessment and optimization of HMW-DNA extraction protocols". Ecology and Evolution. 11 (24): 18505–18513. doi:10.1002/ece3.8447. PMC 8717308. PMID 35003688.
  52. ^ "QU HEALTH LAUNCHES NEW PHD PROGRAMS". www.qu.edu.qa. Retrieved 2018-04-22.
  53. ^ "EXTERNAL RESEARCHERS ADDRESS PREVALENT HEALTH ISSUES AT QUBRC SEMINAR". www.qu.edu.qa. Retrieved 2016-03-10.

External Links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Biomedical_Research_Center&oldid=1144758218"